Alexander City, ALNCT07626411Now EnrollingIRB Ready

Atrial Fibrillation (AF) Clinical Trial in Alexander City, AL

Access cutting-edge atrial fibrillation (af) treatment through this phase 3 clinical trial at a research site in Alexander City. Study-provided care at no cost to qualified participants.

Sponsored by Regeneron Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Alexander City location

Preparing your pre-screening questions…

Expert Care in Alexander City

Access atrial fibrillation (af) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atrial fibrillation (af) treatment provided free

Apply for This Alexander City Location

Check if you qualify for this atrial fibrillation (af) clinical trial in Alexander City, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Alexander City

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Alexander City site if eligible
  4. 4Begin participation

About This Atrial Fibrillation (AF) Study in Alexander City

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. The aim of the study is to see how safe and effective REGN7508 is in preventing stroke and/or systemic embolism in participants with atrial fibrillation and how it compares against participants that will receive apixaban in this study. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Sponsor: Regeneron Pharmaceuticals

Who Can Participate

Inclusion Criteria

Has AF or flutter (paroxysmal or persistent), not considered to be secondary to a reversible cause, and an indication for indefinite anticoagulation treatment as described in the protocol
Meets one of the following:
CHA2DS2-VA \[C: Congestive heart failure; H: Hypertension; A2: Age ≥75 years (double points); D: Diabetes mellitus; S2: Stroke or TIA or Systemic embolism (double points); V: Vascular disease; A: Age 65-74 years\] score ≥2 and Oral Anticoagulant (OAC) naïve OR
CHA2DS2-VA score ≥3 OR
CHA2DS2-VA score of 2 AND at least 1 enrichment criteria as described in the protocol
Must have an International Normalized Ratio (INR) \<2.5 at the time of randomization if taking warfarin or another Vitamin K Antagonist (VKA) Key

Exclusion Criteria

Has a mechanical heart valve prosthesis (Note: transcatheter aortic valve replacement is not an exclusion)
Has known moderate-to-severe mitral stenosis
Has had a successful ablation therapy without documented recurrent AF or a participant after Left Atrial Appendage (LAA) occlusion/exclusion or plan for ablation or LAA occlusion/exclusion within the next 6 months starting from randomization
Had an ischemic stroke within 2 days prior to randomization
Has persistent, uncontrolled hypertension (per investigator's discretion)
Has estimated Glomerular Filtration Rate (eGFR) \<15 mL/min/1.73m2 within 30 days prior to randomization or is on dialysis or expected to be started on dialysis within the next 6 months starting from randomization Note: Other protocol-defined Inclusion/ Exclusion criteria apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Alexander City?

Yes, this clinical trial (NCT07626411) has an active research site in Alexander City, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atrial Fibrillation (AF) Treatment Options in Alexander City, AL

If you're searching for atrial fibrillation (af) treatment options in Alexander City, AL, this clinical trial (NCT07626411) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Alexander City research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced atrial fibrillation (af) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all atrial fibrillation (af) clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Alexander City, AL

See all atrial fibrillation clinical trials recruiting in Alexander City — not just this study.

Browse Atrial Fibrillation Trials in Alexander City →

Browse More Trials by Condition

Atrial Fibrillation TrialsAll Conditions →

Ready to Join in Alexander City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Alexander City, AL